Patents by Inventor Bishnu Joshi

Bishnu Joshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220275049
    Abstract: Provided are novel antigenic polypeptides comprising tumor-associated peptides, and compositions comprising the same. Such antigenic polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using such polypeptides and compositions, methods of treating a disease using such polypeptides and compositions, kits comprising such polypeptides and compositions, and methods of making such compositions.
    Type: Application
    Filed: January 24, 2022
    Publication date: September 1, 2022
    Inventors: Benjamin Maxime MORIN, Mark Arthur FINDEIS, Bishnu JOSHI
  • Publication number: 20220257733
    Abstract: Provided are novel antigenic polypeptides comprising tumor-associated peptides, and compositions comprising the same. Such antigenic polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using the polypeptides and compositions, methods of treating a disease using the polypeptides and compositions, kits comprising the polypeptides and compositions, methods of making the compositions, and antibodies and T cell receptors that specifically bind to the polypeptides.
    Type: Application
    Filed: January 24, 2022
    Publication date: August 18, 2022
    Inventors: Dennis John UNDERWOOD, Paisley Trantham MYERS, Erin Denise JEFFERY, Matthew Joseph PEREZ, Benjamin Maxime MORIN, Mark Arthur FINDEIS, Bishnu JOSHI
  • Publication number: 20220008527
    Abstract: Provided are polypeptides and compositions comprising novel HSP-binding peptides. Such polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using such polypeptides and compositions, methods of treating a disease using such polypeptides and compositions, kits comprising such polypeptides and compositions, and methods of making such compositions.
    Type: Application
    Filed: June 17, 2021
    Publication date: January 13, 2022
    Inventors: Mark Arthur FINDEIS, Benjamin Maxime MORIN, Bishnu JOSHI
  • Patent number: 11065317
    Abstract: Provided are polypeptides and compositions comprising novel HSP-binding peptides. Such polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using such polypeptides and compositions, methods of treating a disease using such polypeptides and compositions, kits comprising such polypeptides and compositions, and methods of making such compositions.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: July 20, 2021
    Assignee: AGENUS INC.
    Inventors: Mark Arthur Findeis, Benjamin Maxime Morin, Bishnu Joshi
  • Publication number: 20200000905
    Abstract: Provided are polypeptides and compositions comprising novel HSP-binding peptides. Such polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using such polypeptides and compositions, methods of treating a disease using such polypeptides and compositions, kits comprising such polypeptides and compositions, and methods of making such compositions.
    Type: Application
    Filed: April 25, 2019
    Publication date: January 2, 2020
    Inventors: Mark Arthur Findeis, Benjamin Maxime Morin, Bishnu Joshi
  • Patent number: 8901276
    Abstract: The present invention is directed to peptide reagents, methods for detecting colon pre-cancer (dysplasia with non-polypoid or polypoid morphology) or cancer using the peptide reagents, and methods for targeting pre-cancerous or cancerous colon cells using the peptide reagents.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: December 2, 2014
    Assignee: The Regents of the University of Michigan
    Inventors: Thomas D. Wang, Sharon Miller, Bishnu Joshi
  • Publication number: 20120219505
    Abstract: The present invention is directed to peptide reagents, methods for detecting colon pre-cancer (dysplasia with non-polypoid or polypoid morphology) or cancer using the peptide reagents, and methods for targeting pre-cancerous or cancerous colon cells using the peptide reagents.
    Type: Application
    Filed: December 19, 2011
    Publication date: August 30, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Thomas D. Wang, Sharon Miller, Bishnu Joshi